Neuroprotection against cochlear synaptopathy and noise-induced hearing loss by a TrkB-FL-derived cell-penetrating peptide
[EN] Noise-induced hearing loss (NIHL) is the second leading cause of deafness globally. However, effective pharmacological treatments remain unavailable. Excitotoxicity, an early NIHL event, is a central mechanism in degeneration of cochlear synapses established between inner hair cells and spiral...
| Autores: | , , |
|---|---|
| Tipo de recurso: | conjunto de datos |
| Fecha de publicación: | 2026 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/424340 |
| Acceso en línea: | http://hdl.handle.net/10261/424340 https://doi.org/10.20350/digitalCSIC/18196 |
| Access Level: | acceso embargado |
| Palabra clave: | Cell-penetrating peptides Cochlear synaptopathy Excitotoxicity Neuroprotection Neurotrophic system Hearing loss Excitotoxicidad Neuroprotección Péptidos penetrantes celulares Pérdida auditiva Sinaptopatía coclear Sistema neurotrófico |
| id |
ES_2fd3c7c710d63ecc4e3e565d0e510630 |
|---|---|
| oai_identifier_str |
oai:digital.csic.es:10261/424340 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Neuroprotection against cochlear synaptopathy and noise-induced hearing loss by a TrkB-FL-derived cell-penetrating peptide |
| title |
Neuroprotection against cochlear synaptopathy and noise-induced hearing loss by a TrkB-FL-derived cell-penetrating peptide |
| spellingShingle |
Neuroprotection against cochlear synaptopathy and noise-induced hearing loss by a TrkB-FL-derived cell-penetrating peptide Torres-Campos, Elena Cell-penetrating peptides Cochlear synaptopathy Excitotoxicity Neuroprotection Neurotrophic system Hearing loss Excitotoxicidad Neuroprotección Péptidos penetrantes celulares Pérdida auditiva Sinaptopatía coclear Sistema neurotrófico |
| title_short |
Neuroprotection against cochlear synaptopathy and noise-induced hearing loss by a TrkB-FL-derived cell-penetrating peptide |
| title_full |
Neuroprotection against cochlear synaptopathy and noise-induced hearing loss by a TrkB-FL-derived cell-penetrating peptide |
| title_fullStr |
Neuroprotection against cochlear synaptopathy and noise-induced hearing loss by a TrkB-FL-derived cell-penetrating peptide |
| title_full_unstemmed |
Neuroprotection against cochlear synaptopathy and noise-induced hearing loss by a TrkB-FL-derived cell-penetrating peptide |
| title_sort |
Neuroprotection against cochlear synaptopathy and noise-induced hearing loss by a TrkB-FL-derived cell-penetrating peptide |
| dc.creator.none.fl_str_mv |
Torres-Campos, Elena Varela-Nieto, Isabel Díaz-Guerra, Margarita |
| author |
Torres-Campos, Elena |
| author_facet |
Torres-Campos, Elena Varela-Nieto, Isabel Díaz-Guerra, Margarita |
| author_role |
author |
| author2 |
Varela-Nieto, Isabel Díaz-Guerra, Margarita |
| author2_role |
author author |
| dc.contributor.none.fl_str_mv |
Comunidad de Madrid Ministerio de Ciencia e Innovación (España) Agencia Estatal de Investigación (España) European Commission elenatorres@iib.uam.es i.varela.nieto@csic.es mdiazguerra@iib.uam.es Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72] |
| dc.subject.none.fl_str_mv |
Cell-penetrating peptides Cochlear synaptopathy Excitotoxicity Neuroprotection Neurotrophic system Hearing loss Excitotoxicidad Neuroprotección Péptidos penetrantes celulares Pérdida auditiva Sinaptopatía coclear Sistema neurotrófico |
| topic |
Cell-penetrating peptides Cochlear synaptopathy Excitotoxicity Neuroprotection Neurotrophic system Hearing loss Excitotoxicidad Neuroprotección Péptidos penetrantes celulares Pérdida auditiva Sinaptopatía coclear Sistema neurotrófico |
| description |
[EN] Noise-induced hearing loss (NIHL) is the second leading cause of deafness globally. However, effective pharmacological treatments remain unavailable. Excitotoxicity, an early NIHL event, is a central mechanism in degeneration of cochlear synapses established between inner hair cells and spiral ganglion neurons. This excitotoxic damage can trigger the degradation of the neurotrophic TrkB receptor, thereby inhibiting brain-derived neurotrophic factor (BDNF) signaling and challenging neurotrophin-based therapies for hearing loss. Here, we evaluate the therapeutic potential in the inner ear of MTFL457, a cell-penetrating peptide that prevents TrkB-FL degradation during brain excitotoxicity. This peptide efficiently distributes through cochlear cells in both ex vivo (explants) and in vivo (noise-overexposed) models. In explants undergoing excitotoxicity, MTFL457 prevents TrkB-FL dysregulation, recovers downstream prosurvival signaling, and reduces neurodegeneration and cochlear synaptopathy. Furthermore, despite sexual dimorphism in noise damage susceptibility in vivo, MTFL457 preserves hearing function and synapses, demonstrating its therapeutic potential for NIHL and possibly other types of sensorineural hearing loss likewise associated with excitotoxicity. |
| publishDate |
2026 |
| dc.date.none.fl_str_mv |
2026 2026 2026 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/dataset http://purl.org/coar/resource_type/c_ddb1 |
| format |
dataset |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/424340 https://doi.org/10.20350/digitalCSIC/18196 |
| url |
http://hdl.handle.net/10261/424340 https://doi.org/10.20350/digitalCSIC/18196 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
#PLACEHOLDER_PARENT_METADATA_VALUE# #PLACEHOLDER_PARENT_METADATA_VALUE# #PLACEHOLDER_PARENT_METADATA_VALUE# S2020/BMD-17454 info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2022-137710OB-I00 info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2023-147347OB-I00 Sí |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/embargoedAccess |
| eu_rights_str_mv |
embargoedAccess |
| dc.format.none.fl_str_mv |
application/pdf application/msword application/vnd.ms-excel |
| dc.publisher.none.fl_str_mv |
DIGITAL.CSIC |
| publisher.none.fl_str_mv |
DIGITAL.CSIC |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869405503914770432 |
| spelling |
Neuroprotection against cochlear synaptopathy and noise-induced hearing loss by a TrkB-FL-derived cell-penetrating peptideTorres-Campos, ElenaVarela-Nieto, IsabelDíaz-Guerra, MargaritaCell-penetrating peptidesCochlear synaptopathyExcitotoxicityNeuroprotectionNeurotrophic systemHearing lossExcitotoxicidadNeuroprotecciónPéptidos penetrantes celularesPérdida auditivaSinaptopatía coclearSistema neurotrófico[EN] Noise-induced hearing loss (NIHL) is the second leading cause of deafness globally. However, effective pharmacological treatments remain unavailable. Excitotoxicity, an early NIHL event, is a central mechanism in degeneration of cochlear synapses established between inner hair cells and spiral ganglion neurons. This excitotoxic damage can trigger the degradation of the neurotrophic TrkB receptor, thereby inhibiting brain-derived neurotrophic factor (BDNF) signaling and challenging neurotrophin-based therapies for hearing loss. Here, we evaluate the therapeutic potential in the inner ear of MTFL457, a cell-penetrating peptide that prevents TrkB-FL degradation during brain excitotoxicity. This peptide efficiently distributes through cochlear cells in both ex vivo (explants) and in vivo (noise-overexposed) models. In explants undergoing excitotoxicity, MTFL457 prevents TrkB-FL dysregulation, recovers downstream prosurvival signaling, and reduces neurodegeneration and cochlear synaptopathy. Furthermore, despite sexual dimorphism in noise damage susceptibility in vivo, MTFL457 preserves hearing function and synapses, demonstrating its therapeutic potential for NIHL and possibly other types of sensorineural hearing loss likewise associated with excitotoxicity.[ES] La pérdida auditiva inducida por ruido (NIHL, por sus siglas en inglés) constituye la segunda causa más frecuente de sordera a nivel mundial. No obstante, en la actualidad no se dispone de tratamientos farmacológicos eficaces. La excitotoxicidad, un evento temprano en la NIHL, representa un mecanismo central en la degeneración de las sinapsis cocleares establecidas entre las células ciliadas internas y las neuronas del ganglio espiral. Este daño excitotóxico puede desencadenar la degradación del receptor neurotrófico TrkB, inhibiendo así las vías de señalización mediadas por el factor neurotrófico derivado del cerebro (BDNF) y limitando la eficacia de las terapias para la pérdida auditiva basadas en neurotrofinas. En este estudio, evaluamos el potencial terapéutico en el oído interno de MTFL457, un péptido capaz de penetrar en las células, que previene la degradación de la isoforma completa del receptor TrkB (TrkB-FL) durante procesos de excitotoxicidad cerebral. Este péptido se distribuye eficazmente en las células cocleares tanto en modelos ex vivo (explantes) como in vivo (exposición excesiva al ruido). En explantes sometidos a excitotoxicidad, MTFL457 previene la desregulación de TrkB-FL, preserva las vías de señalización prosupervivencia y reduce la neurodegeneración y la sinaptopatía coclear. Además, a pesar de la existencia de un dimorfismo sexual en la susceptibilidad al daño por ruido in vivo, MTFL457 preserva la función auditiva y la integridad sináptica, lo que pone de manifiesto su potencial terapéutico para la NIHL y, posiblemente, para otros tipos de pérdida auditiva neurosensorial igualmente asociados con procesos de excitotoxicidad.This research was funded by an Industrial Doctorate project (IND2020/BMD-17454) from Comunidad de Madrid, with the participation of Alodia Farmacéutica S.L., and by MICIU/AEI/10.13039/501100011033/FEDER, UE, as part of projects PID2022-137710OB-I00 granted to Margarita Díaz-Guerra and PID2023−147347OB-I00 granted to Isabel Varela-Nieto.Peer reviewedDIGITAL.CSICComunidad de MadridMinisterio de Ciencia e Innovación (España)Agencia Estatal de Investigación (España)European Commissionelenatorres@iib.uam.esi.varela.nieto@csic.esmdiazguerra@iib.uam.esConsejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]202620262026info:eu-repo/semantics/datasethttp://purl.org/coar/resource_type/c_ddb1application/pdfapplication/mswordapplication/vnd.ms-excelhttp://hdl.handle.net/10261/424340https://doi.org/10.20350/digitalCSIC/18196reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Inglés#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#S2020/BMD-17454info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2022-137710OB-I00info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2023-147347OB-I00Síinfo:eu-repo/semantics/embargoedAccessoai:digital.csic.es:10261/4243402026-05-22T06:33:51Z |
| score |
15,812429 |